Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation

Bibliographic Details
Main Authors:	N Woolacott, Y Bravo Vergel, N Hawkins, A Kainth, Z Khadjesari, K Misso, K Light, C Asseburg, S Palmer, K Claxton, I Bruce, M Sculpher, R Riemsma
Format:	Article
Language:	English
Published:	NIHR Journals Library 2006-09-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta10310

Similar Items

Etanercept and efalizumab for the treatment of psoriasis: a systematic review
by: N Woolacott, et al.
Published: (2006-11-01)

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
by: M Rodgers, et al.
Published: (2011-02-01)

Golimumab for the treatment of psoriatic arthritis
by: H Yang, et al.
Published: (2011-05-01)

Etanercept (Enbrel) in the treatment of psoriatic arthritis
by: T V Korotaeva
Published: (2009-12-01)

Therapy for psoriatic arthritis with infliximab
by: V V Badokin, et al.
Published: (2009-03-01)

Therapy for psoriatic arthritis with infliximab
by: V V Badokin, et al.
Published: (2009-03-01)

Evaluation of effectiveness and safety of Etanercept in children with Juvenile psoriatic arthritis
by: K. V. Aleksanyan, et al.
Published: (2020-09-01)

Etanercept-Induced Hypoglycemia in a Patient With Psoriatic Arthritis and Diabetes
by: Emily C. Pfeifer MD, et al.
Published: (2017-09-01)

Using etanercept to maintain remission of psoriatic arthritis during pregnancy
by: Ibrahim A Al-Homood, et al.
Published: (2014-01-01)

A Case of Sclerosing Mesenteritis during Etanercept Therapy for Psoriatic Arthritis
by: Aleksandra Bukiej
Published: (2020-01-01)

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis
by: Kivelevitch D, et al.
Published: (2014-04-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
by: Viola Sacchi, et al.
Published: (2010-06-01)

Infliximab no tratamento da artrite psoriásica grave Infliximab in treatment of severe psoriatic arthritis
by: Adriano Jaime Consorte Loyola, et al.
Published: (2005-10-01)

Infliximab Induces Increase in Triglyceride Levels in Psoriatic Arthritis Patients
by: Karla R. Castro, et al.
Published: (2011-01-01)

Infliximab-Induced Aseptic Meningitis during the Treatment of Psoriatic Arthritis
by: Yuki Matsuura-Otsuki, et al.
Published: (2017-05-01)

Development of Eosinophilic Fasciitis during Infliximab Therapy for Psoriatic Arthritis
by: Richard Hariman, et al.
Published: (2016-01-01)

Pyogenic Baker cyst in a patient with psoriatic arthritis during etanercept therapy
by: Keng-Yi Wu, et al.
Published: (2015-05-01)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
by: P. Jobanputra, et al.
Published: (2002-01-01)

Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis
by: A. Minosi, et al.
Published: (2011-06-01)

A Case of Phlegmonous Gastritis in a Patient with Psoriatic Arthritis on Infliximab
by: Laurence De Davide, et al.
Published: (2018-01-01)

Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain: A Systematic Review
by: Lluís Puig, et al.
Published: (2019-05-01)

Comprehensive molecular and clinical analysis of adalimumab and etanercept therapeutic potential in patients with psoriatic arthritis
by: Dominika Wcisło-Dziadecka, et al.
Published: (2020-05-01)

Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registry
by: Gudbjornsson B, et al.
Published: (2018-05-01)

Additional effect of etanercept or infliximab on the liver function tests of patients with rheumatoid arthritis: a cohort study
by: Akhlaghi S, et al.
Published: (2018-10-01)

Recurrent hepatotoxicity associated with etanercept and adalimumab but not with infliximab in a patient with rheumatoid arthritis Hepatotoxicidad recurrente asociada a etanercept y adalimumab pero no a infliximab en una paciente con artritis reumatoide
by: José Carlos Titos-Arcos, et al.
Published: (2012-05-01)

Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison
by: Philip Mease, et al.
Published: (2019-07-01)

Avaliação econômica das anticitocinas adalimumabe, etanercepte e infliximabe no tratamento da artrite reumatoide no Estado do Paraná Economic evaluation of anticitokines adalimumab, etanercept and infliximab for treatment of rheumatoid arthritis in Paraná State, Brazil
by: Rafael Venson, et al.
Published: (2011-01-01)

EFFICACY OF ETANERCEPT TREATMENT AS A SECOND TNF α INHIBITOR IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS AND PRIMARY AND SECONDARY INEFFICIENCY OR INTOLERANCE OF INFLIXIMAB
by: E. I. Alexeeva, et al.
Published: (2012-11-01)

Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany
by: Waller J, et al.
Published: (2017-03-01)

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
by: Y-F Chen, et al.
Published: (2006-11-01)

LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH AUTOIMMUNE DISEASES TREATED WITH INFLIXIMAB AND ETANERCEPT
by: Luis Gabriel Parra-Lara
Published: (2019-04-01)

Mapping the certolizumab pegol epitope on TNF and comparison with infliximab, adalimumab and etanercept
by: Henry Alistair I, et al.
Published: (2011-11-01)

Infliximab and Etanercept Are Equally Effective in Reducing Enterocyte APOPTOSIS in Experimental Colitis
by: Walter Fries, Carmelo Muja, Carmela Crisafulli, Giuseppe Costantino, Giuseppe Longo, Salvatore Cuzzocrea, Emanuela Mazzon
Published: (2008-01-01)

Divergent gene activation in peripheral blood and tissues of patients with rheumatoid arthritis, psoriatic arthritis and psoriasis following infliximab therapy.
by: Alexander Rosenberg, et al.
Published: (2014-01-01)

Ankylosing Spondylitis and Rheumatoid Arthritis: Serum Levels of TNF-α and Its Soluble Receptors during the Course of Therapy with Etanercept and Infliximab
by: Martin Schulz, et al.
Published: (2014-01-01)

Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination
by: Vibeke Strand, et al.
Published: (2021-04-01)

Decreased Injection Site Pain Associated with Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized Controlled Trial
by: Stanley Cohen, et al.
Published: (2019-03-01)

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis.
by: Monika Hebeisen, et al.
Published: (2019-01-01)

Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany
by: Evelien Moorkens, et al.
Published: (2020-10-01)

Economic impact of biosimilar drugs in Italy: past, present and future of infliximab and etanercept
by: Andrea Marcellusi, et al.
Published: (2017-07-01)